Federal Research Centre “Fundamentals of Biotechnology” of the Russian Academy of Sciences (Research Centre of Biotechnology RAS), 33-2 Leninsky Prospect, 119071 Moscow, Russia
Auto-generated profile, based on publicly available information
Andrey M. Tsedilin
Federal Research Centre “Fundamentals of Biotechnology” of the Russian Academy of Sciences (Research Centre of Biotechnology RAS), 33-2 Leninsky Prospect, 119071 Moscow, Russia
R–NHC coupling was previously considered as a process of degradation of M/NHC species; however recent studies have pointed out that it may be responsible for the generation of catalytically active NHC-free complexes and/or metallic nanoparticles. Therefore, a detailed and systematic study of R–NHC coupling for various carbene ligands is an important topic. In the present article this process has been studied for reactive aryl iodide coupling partners by a combination of quantum chemical calculations and continuous reaction monitoring via pressurized sample infusion electrospray ionization mass spectrometry (PSI-ESI-MS). DFT calculations revealed a strong tendency of (NHC)Pd(Ph)(I)DMF complexes bearing various N-heterocyclic carbene (NHC) ligands to undergo Ph–NHC coupling. Calculated energy barriers of these reactions lie in the range of 17.9–25.1 kcal mol−1. Ph–NHC coupling is thermodynamically more favorable for the complexes containing unsaturated NHC ligands with bulky substituents. NBO analysis suggests that the process of Ph–NHC formation is similar for different NHC ligands. In order to confirm the results of theoretical studies, a series of ESI-MS reaction monitoring experiments were performed for (NHC)Pd(I)2(Py) and (NHC)Pd(Cl)(η3–1-Ph-C3H4) complexes interacting with iodobenzene, where Ph–NHC coupling products were observed in all cases. As direct experimental evidence, the formation of colloidal Pd-containing nanoparticles was observed in situ for different Pd/NHC complexes in the studied reaction mixtures.
• Peptide biosynthesis in thermostable chaperone-based fusion • Model peptide enfuvirtide sequence inserted between Ser 199 and Tyr 201 of modified GroEL chaperone • Host proteins thermal denaturation as purification step • Methionineless fusion partner and cyanogen bromide treatment to produce free peptide
Pyrrolo[2,3-e]indazole is a promising scaffold for the development of novel neuraminidase inhibitors that are active against influenza A virus and S. pneumoniae.